Eli Lilly and Company (LLY) has a consensus analyst rating of Buy, based on 45 analysts covering the stock. Of those, 33 recommend buying, 9 recommend holding, and 3 recommend selling.
The analyst consensus price target for LLY is $1,243.95, representing a +34.8% upside from the current price of $922.5. Price targets range from a low of $985.00 to a high of $1,350.00.
